论文部分内容阅读
随着科技的进步、新的免疫抑制药物的应用,尸体肾移植后人/肾存活的病例不断增多,但超过5年以上长期存活者比例仍不高。本院有一例存活至今已超过6年,并已恢复工作,兹报道如下。 患者女性,30岁。因慢性肾炎11年,水肿、恶心呕吐、尿量减少一个月,于1984年12月7日入院。体检:慢性病容,颜面及下肢水肿,血压27.9/18.6kPa,血红蛋白50g/L,白细胞6.4×10~9/L,N78％,L20％,E2％,血小板104×10~9/L,尿蛋白+++,比重1.010,镜检白细胞0～3/HP,红细胞0～1/HP,颗粒管型0～6/HP,BUN34.27mmol/L,Cr 1706mmol/L,CO_2CP5.03mmol/L,血型“B”,肝功能正常,HBsAg(一),抗核抗体,类风湿因子及尿FDP均阴
With advances in technology and new immunosuppressive drugs, the number of human / kidney survivors after cadaveric kidney transplantation has been increasing, but the proportion of long-term survivors over 5 years is still not high. A case of this hospital has survived for more than 6 years and has resumed its work. We have the report below. Patient female, 30 years old. Due to chronic nephritis 11 years, edema, nausea and vomiting, urine output decreased by one month, on December 7, 1984 admission. Physical examination: Chronic disease, facial and lower extremity edema, blood pressure 27.9 / 18.6kPa, hemoglobin 50g / L, white blood cells 6.4 × 10-9 / L, N78%, L20%, E2%, platelets 104 × 10 ~ 9 / L, urinary protein +++, specific gravity 1.010, microscope leukocyte 0-3 / HP, erythrocyte 0-1 / HP, granular tube 0-6 / HP, BUN34.27mmol / L, Cr 1706mmol / L, CO_2CP5.03mmol / L, “B”, normal liver function, HBsAg (a), anti-nuclear antibody, rheumatoid factor and urinary FDP were Yin